Results 141 to 150 of about 81,011 (193)
Some of the next articles are maybe not open access.

Transdermal selegiline

Drugs of Today, 2007
Although older monoamine oxidase inhibitors (MAOIs) are effective in the treatment of depressive disorders, they are underutilized in clinical practice due to main concerns about interaction with tyramine-containing food, and side effects. Efforts to address these safety issues led to the development of a transdermal formulation of selegiline, called ...
Ashwin A, Patkar   +2 more
openaire   +2 more sources

Transdermal Buprenorphine

Drugs, 2003
Buprenorphine is a low molecular weight, lipophilic, opioid analgesic. Recently, a transdermal matrix patch formulation of buprenorphine has become available in three dosage strengths designed to release buprenorphine at 35, 52.5 and 70 micro g/h over a 72-hour period. At least satisfactory analgesia with minimal requirement for rescue medication (
Hannah C, Evans, Stephanie E, Easthope
openaire   +2 more sources

Transdermal Oxybutynin

Drugs, 2009
*Oxybutynin inhibits contraction of the detrusor muscle in the overactive bladder by binding to muscarinic M(3) receptors and blocking acetylcholinergic activation. *The transdermal oxybutynin system, applied twice weekly, delivers continuous oxybutynin over a 96-hour patch wear period. The transdermal route of administration avoids the extensive first-
Claudine M, Baldwin, Gillian M, Keating
openaire   +2 more sources

Transdermal Granisetron

Drugs, 2009
Granisetron is a highly selective serotonin 5-HT(3) receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting. The transdermal granisetron system delivers continuous granisetron (3.1 mg/day) into the systemic circulation (via passive diffusion) for up to 7 days. In a large phase III trial in cancer patients receiving multi-day (
Sean T, Duggan, Monique P, Curran
openaire   +2 more sources

Transdermal Electrochemical Monitoring of Glucose via High‐Density Silicon Microneedle Array Patch

Advanced Functional Materials, 2021
Current technology for blood glucose level monitoring is mainly based on the invasive finger‐prick extraction of a small drop of blood using a lancet and measured via a handheld glucometer, which is not conducive to continuous measurements.
Muamer Dervisevic   +6 more
semanticscholar   +1 more source

Permeation enhancers in transdermal drug delivery: benefits and limitations

Expert Opinion on Drug Delivery, 2020
Introduction: Transdermal drug delivery has several clinical benefits over conventional routes of drug administration. To open the transdermal route for a wider range of drugs, including macromolecules, numerous physical and chemical techniques to ...
Andrej Kováčik   +2 more
semanticscholar   +1 more source

Transdermal Testosterone

Drugs, 1998
Nightly application of testosterone transdermal (TTD) system to nonscrotal sites in men with hypogonadism results in a 24-hour serum testosterone concentration profile which mimics the circadian pattern observed in healthy young men. The system also normalises dihydrotestosterone/testosterone and estradiol/testosterone ratios and reduces luteinising ...
K J, McClellan, K L, Goa
openaire   +3 more sources

Transdermal iontophoresis

Expert Opinion on Drug Delivery, 2005
Iontophoresis is a technique used to enhance the transdermal delivery of compounds through the skin via the application of a small electric current. By the process of electromigration and electro-osmosis, iontophoresis increases the permeation of charged and neutral compounds, and offers the option for programmed drug delivery.
Priya, Batheja   +5 more
openaire   +2 more sources

A Review on Transdermal Drug Delivery Systems

International Journal of Science Architecture Technology and Environment
R ecently delivery of drugs through the skin is being a challenging area for research because of barrier properties exhibit by the outermost layer of skin stratum corneum. The transdermal drug delivery system has offers significant clinical benefits over
M. Choudhari
semanticscholar   +1 more source

Recent Advances in Oral and Transdermal Protein Delivery Systems.

Angewandte Chemie, 2022
Protein and peptide drugs are predominantly administered by injection to achieve high bioavailability, but this greatly compromises patient compliance. Oral and transdermal drug delivery with minimal invasiveness and high adherence represent attractive ...
Yinxian Yang   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy